I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Girolomoni, G.
321
results:
Search for persons
X
Format
Online (321)
Mediatypes
Articles (Online) (167)
OpenAccess-fulltext (154)
Languages
english (304)
more...
french (10)
italian (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Long‐term effectiveness and tolerability of apremilast in p..:
Gargiulo, L.
;
Ibba, L.
;
Malagoli, P.
...
Journal of the European Academy of Dermatology and Venereology. , 2024
Link:
https://doi.org/10.1111/..
?
2
P1019 "Totality-of-the-evidence" of proposed ustekinumab bi..:
Armuzzi, A
;
Girolomoni, G
;
Feldman, S
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1841-i1843 , 2024
Link:
https://doi.org/10.1093/..
?
3
Upadacitinib improves symptoms of concomitant allergic rhin..:
Gargiulo, L.
;
Ibba, L.
;
Piscazzi, F.
...
Journal of the European Academy of Dermatology and Venereology. , 2024
Link:
https://doi.org/10.1111/..
?
4
A risankizumab super responder profile identified by long‐t..:
Gargiulo, L.
;
Ibba, L.
;
Malagoli, P.
...
Journal of the European Academy of Dermatology and Venereology. 38 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1111/..
?
5
Spesolimab in patients with flare of generalized pustular p..:
Bellinato, F.
;
Gisondi, P.
;
Dattola, A.
...
Journal of the European Academy of Dermatology and Venereology. 38 (2023) 5 - p. , 2023
Link:
https://doi.org/10.1111/..
?
6
First update of the living European guideline (EuroGuiDerm)..:
Wollenberg, A.
;
Kinberger, M.
;
Arents, B.
...
Journal of the European Academy of Dermatology and Venereology. 37 (2023) 11 - p. , 2023
Link:
https://doi.org/10.1111/..
?
7
European guideline (EuroGuiDerm) on atopic eczema: part I –..:
Wollenberg, A.
;
Kinberger, M.
;
Arents, B.
...
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 9 - p. 1409-1431 , 2022
Link:
https://doi.org/10.1111/..
?
8
European guideline (EuroGuiDerm) on atopic eczema – part II..:
Wollenberg, A.
;
Kinberger, M.
;
Arents, B.
...
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 11 - p. 1904-1926 , 2022
Link:
https://doi.org/10.1111/..
?
9
Monkeypox virus infection: what dermatologist needs to know:
Bellinato, F.
;
Gisondi, P.
;
Girolomoni, G.
Journal of the European Academy of Dermatology and Venereology. , 2022
Link:
https://doi.org/10.1111/..
?
10
Upadacitinib in patients with resistant atopic dermatitis: ..:
Dal Bello, G.
;
Schena, D.
;
Girolomoni, G.
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 9 - p. 1499-1500 , 2022
Link:
https://doi.org/10.1111/..
?
11
Reduction of cutaneous advanced glycation end products leve..:
Maurelli, M.
;
Bellinato, F.
;
Gisondi, P.
.
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 8 - p. , 2022
Link:
https://doi.org/10.1111/..
?
12
Is risankizumab as needed administration a good option for ..:
Gisondi, P.
;
Maurelli, M.
;
Bellinato, F.
.
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 9 - p. , 2022
Link:
https://doi.org/10.1111/..
?
13
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevan..:
Gisondi, P.
;
Bellinato, F.
;
Girolomoni, G.
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 2 - p. 165-166 , 2022
Link:
https://doi.org/10.1111/..
?
14
Risk of non-alcoholic fatty liver disease in patients with ..:
Bellinato, F.
;
Gisondi, P.
;
Mantovani, A.
..
Journal of Endocrinological Investigation. 45 (2022) 7 - p. 1277-1288 , 2022
Link:
https://doi.org/10.1007/..
?
15
The Combination of Dupilumab with Other Monoclonal Antibodi..:
Gisondi, P.
;
Maurelli, M.
;
Costanzo, A.
..
Dermatology and Therapy. 13 (2022) 1 - p. 7-12 , 2022
Link:
https://doi.org/10.1007/..
1-15